Hey mate,
In a nutshell;
I guess we'll soon find out about the pump and dump; it's just a matter of time. Phase 3 is usually where the chaos ends for the biotech industry, and things start to settle down, at least based on my research. If the results are positive, don't you think it could attract the attention of companies looking for a takeover?
If there were a pill treatment for diabetes, how many do you think would stick with the injection? Consider new customers, which of those would rather the pill over the injection?
Apinmed is definitely one to watch, but using the Zepbound and Ozempic example, don't you think there's room for more than one drug for OSA?